Becton Dickinson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Becton Dickinson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BDX

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. 

CEO
Thomas E. Polen
CEOThomas E. Polen
Employees
72,000
Employees72,000
Headquarters
Franklin Lakes, New Jersey
HeadquartersFranklin Lakes, New Jersey
Founded
1897
Founded1897
Employees
72,000
Employees72,000

BDX Key Statistics

Market cap
55.32B
Market cap55.32B
Price-Earnings ratio
33.36
Price-Earnings ratio33.36
Dividend yield
2.14%
Dividend yield2.14%
Average volume
2.17M
Average volume2.17M
High today
$194.74
High today$194.74
Low today
$193.10
Low today$193.10
Open price
$193.74
Open price$193.74
Volume
577.72K
Volume577.72K
52 Week high
$251.99
52 Week high$251.99
52 Week low
$162.29
52 Week low$162.29

Stock Snapshot

As of today, Becton Dickinson(BDX) shares are valued at $194.02. The company's market cap stands at 55.32B, with a P/E ratio of 33.36 and a dividend yield of 2.1%.

On 2025-11-30, Becton Dickinson(BDX) stock traded between a low of $193.10 and a high of $194.74. Shares are currently priced at $194.02, which is +0.5% above the low and -0.4% below the high.

The Becton Dickinson(BDX)'s current trading volume is 577.72K, compared to an average daily volume of 2.17M.

During the past year, Becton Dickinson(BDX) stock moved between $162.29 at its lowest and $251.99 at its peak.

During the past year, Becton Dickinson(BDX) stock moved between $162.29 at its lowest and $251.99 at its peak.

BDX News

Simply Wall St 2d
Becton Dickinson: Evaluating Valuation After European Launch of Surgiphor and Recent Strategic Moves

Becton Dickinson (BDX) unveiled its BD Surgiphor Surgical Wound Irrigation System across select European countries following CE approval for the product. This m...

Becton Dickinson: Evaluating Valuation After European Launch of Surgiphor and Recent Strategic Moves
Simply Wall St 4d
Becton Dickinson Margin Decline Reinforces Bearish Revenue Growth Narrative in FY2025

Becton Dickinson (BDX) just posted its FY 2025 Q4 results, turning in revenue of $5.9 billion and net income of $493 million, with EPS at $1.72. Over the past y...

Becton Dickinson Margin Decline Reinforces Bearish Revenue Growth Narrative in FY2025
TipRanks 4d
Becton Dickinson Faces Risks in Biosciences and Diagnostic Merger with Waters

Becton, Dickinson and Co (BDX) has disclosed a new risk, in the Corporate Activity and Growth category. TipRanks Black Friday Sale Claim 60% off TipRanks Prem...

Analyst ratings

67%

of 15 ratings
Buy
33.3%
Hold
66.7%
Sell
0%

More BDX News

Simply Wall St 7d
Becton Dickinson's Dividend Will Be Increased To $1.05

The board of Becton, Dickinson and Company ( ) has announced that it will be paying its dividend of $1.05 on the 31st of December, an increased payment from las...

Becton Dickinson's Dividend Will Be Increased To $1.05

People also own

Based on the portfolios of people who own BDX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.